Hyperactive CDK2 Activity in Basal-like Breast Cancer Imposes a Genome Integrity Liability that can be Exploited by Targeting DNA Polymerase Epsilon

Name: Hyperactive CDK2 Activity in Basal-like Breast Cancer Imposes a Genome Integrity Liability that can be Exploited by Targeting DNA Polymerase Epsilon
Creator: Richard Possemato
Published: 2020-10-27T07:46:42.274Z
Keywords: Primary Data

Possemato, Richard

doi:10.17632/xvgb9rg7b7.1

Hyperactive CDK2 Activity in Basal-like Breast Cancer Imposes a Genome Integrity Liability that can be Exploited by Targeting DNA Polymerase Epsilon

Published: 27-10-2020| Version 1 | DOI: 10.17632/xvgb9rg7b7.1

Contributor:

Richard Possemato

Description

Data from "Hyperactive CDK2 Activity in Basal-like Breast Cancer Imposes a Genome Integrity Liability that can be Exploited by Targeting DNA Polymerase Epsilon"

Hyperactive CDK2 Activity in Basal-like Breast Cancer Imposes a Genome Integrity Liability that can be Exploited by Targeting DNA Polymerase Epsilon

Description

Files